223 related articles for article (PubMed ID: 26366730)
1. Cytokine Response after Stimulation with Key Commensal Bacteria Differ in Post-Infectious Irritable Bowel Syndrome (PI-IBS) Patients Compared to Healthy Controls.
Sundin J; Rangel I; Repsilber D; Brummer RJ
PLoS One; 2015; 10(9):e0134836. PubMed ID: 26366730
[TBL] [Abstract][Full Text] [Related]
2. Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome.
Compare D; Rocco A; Coccoli P; Angrisani D; Sgamato C; Iovine B; Salvatore U; Nardone G
BMC Gastroenterol; 2017 Apr; 17(1):53. PubMed ID: 28410580
[TBL] [Abstract][Full Text] [Related]
3. Imbalanced shift of cytokine expression between T helper 1 and T helper 2 (Th1/Th2) in intestinal mucosa of patients with post-infectious irritable bowel syndrome.
Chen J; Zhang Y; Deng Z
BMC Gastroenterol; 2012 Jul; 12():91. PubMed ID: 22816602
[TBL] [Abstract][Full Text] [Related]
4. Serum and colonic mucosal immune markers in irritable bowel syndrome.
Chang L; Adeyemo M; Karagiannides I; Videlock EJ; Bowe C; Shih W; Presson AP; Yuan PQ; Cortina G; Gong H; Singh S; Licudine A; Mayer M; Tache Y; Pothoulakis C; Mayer EA
Am J Gastroenterol; 2012 Feb; 107(2):262-72. PubMed ID: 22158028
[TBL] [Abstract][Full Text] [Related]
5. Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome.
Ivashkin V; Poluektov Y; Kogan E; Shifrin O; Sheptulin A; Kovaleva A; Kurbatova A; Krasnov G; Poluektova E
PLoS One; 2021; 16(6):e0252930. PubMed ID: 34115808
[TBL] [Abstract][Full Text] [Related]
6. Effect of mild moxibustion on intestinal microbiota and NLRP6 inflammasome signaling in rats with post-inflammatory irritable bowel syndrome.
Bao CH; Wang CY; Li GN; Yan YL; Wang D; Jin XM; Wu LY; Liu HR; Wang XM; Shi Z; Wu HG
World J Gastroenterol; 2019 Aug; 25(32):4696-4714. PubMed ID: 31528095
[TBL] [Abstract][Full Text] [Related]
7. Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress.
Sundin J; Rangel I; Fuentes S; Heikamp-de Jong I; Hultgren-Hörnquist E; de Vos WM; Brummer RJ
Aliment Pharmacol Ther; 2015 Feb; 41(4):342-51. PubMed ID: 25521822
[TBL] [Abstract][Full Text] [Related]
8. Herbal prescription Chang'an II repairs intestinal mucosal barrier in rats with post-inflammation irritable bowel syndrome.
Wang FY; Su M; Zheng YQ; Wang XG; Kang N; Chen T; Zhu EL; Bian ZX; Tang XD
Acta Pharmacol Sin; 2015 Jun; 36(6):708-15. PubMed ID: 25960135
[TBL] [Abstract][Full Text] [Related]
9. Increased Ileal Immunoglobulin A Production and Immunoglobulin A-Coated Bacteria in Diarrhea-Predominant Irritable Bowel Syndrome.
Liu Y; Yuan X; Li L; Lin L; Zuo X; Cong Y; Li Y
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00146. PubMed ID: 32352710
[TBL] [Abstract][Full Text] [Related]
10. Aberrant mucosal lymphocyte number and subsets in the colon of post-infectious irritable bowel syndrome patients.
Sundin J; Rangel I; Kumawat AK; Hultgren-Hörnquist E; Brummer RJ
Scand J Gastroenterol; 2014 Sep; 49(9):1068-75. PubMed ID: 24919810
[TBL] [Abstract][Full Text] [Related]
11. Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome.
Bennet SM; Polster A; Törnblom H; Isaksson S; Capronnier S; Tessier A; Le Nevé B; Simrén M; Öhman L
Am J Gastroenterol; 2016 Aug; 111(8):1165-76. PubMed ID: 27272011
[TBL] [Abstract][Full Text] [Related]
12. Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome.
Yang B; Zhou X; Lan C
BMC Gastroenterol; 2015 Apr; 15():43. PubMed ID: 25886744
[TBL] [Abstract][Full Text] [Related]
13. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome.
Bednarska O; Walter SA; Casado-Bedmar M; Ström M; Salvo-Romero E; Vicario M; Mayer EA; Keita ÅV
Gastroenterology; 2017 Oct; 153(4):948-960.e3. PubMed ID: 28711627
[TBL] [Abstract][Full Text] [Related]
15. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.
Shukla R; Ghoshal U; Dhole TN; Ghoshal UC
Dig Dis Sci; 2015 Oct; 60(10):2953-62. PubMed ID: 25784074
[TBL] [Abstract][Full Text] [Related]
16. Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype.
Belmonte L; Beutheu Youmba S; Bertiaux-Vandaële N; Antonietti M; Lecleire S; Zalar A; Gourcerol G; Leroi AM; Déchelotte P; Coëffier M; Ducrotté P
PLoS One; 2012; 7(8):e42777. PubMed ID: 23028414
[TBL] [Abstract][Full Text] [Related]
17. Altered intestinal antibacterial gene expression response profile in irritable bowel syndrome is linked to bacterial composition and immune activation.
Bennet SMP; Sundin J; Magnusson MK; Strid H; Tap J; Derrien M; Le Nevé B; Doré J; Törnblom H; Simrén M; Öhman L
Neurogastroenterol Motil; 2018 Dec; 30(12):e13468. PubMed ID: 30230134
[TBL] [Abstract][Full Text] [Related]
18. AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms.
Meynier M; Baudu E; Rolhion N; Defaye M; Straube M; Daugey V; Modoux M; Wawrzyniak I; Delbac F; Villéger R; Méleine M; Borras Nogues E; Godfraind C; Barnich N; Ardid D; Poirier P; Sokol H; Chatel JM; Langella P; Livrelli V; Bonnet M; Carvalho FA
Gut Microbes; 2022; 14(1):2022997. PubMed ID: 35090380
[TBL] [Abstract][Full Text] [Related]
19. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
[TBL] [Abstract][Full Text] [Related]
20. Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS.
Edogawa S; Edwinson AL; Peters SA; Chikkamenahalli LL; Sundt W; Graves S; Gurunathan SV; Breen-Lyles M; Johnson S; Dyer R; Graham R; Chen J; Kashyap P; Farrugia G; Grover M
Gut; 2020 Jan; 69(1):62-73. PubMed ID: 30923071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
